Crown Reserve Acquisition Corp. I (ticker: CRAC) is a Special Purpose Acquisition Company (SPAC) — a shell company with no operations, no revenue, and no customers. Crown Reserve raised $172.5M in its IPO in November 2025, and those proceeds sit in a Trust Account invested in U.S. government securities. The company's sole purpose is to identify a private company, negotiate a merger (a "Business Combination"), and take that company public. Crown Reserve has until November 2026, extendable to February 2027, to complete a deal; if no deal closes, public shareholders get their money back from the Trust Account. Crown Reserve says it will focus on North American companies with enterprise values between $500M and $5B, with no industry restriction, led by a management team with backgrounds in technology, financial services, and healthcare technology. The Sponsor's economics come primarily from the "promote" — Founder shares acquired for $25,000 that convert into equity in the combined company upon deal close, representing significant dilution to public shareholders. Public shareholders' returns depend entirely on the quality of the acquisition target Crown Reserve finds. As of the filing date, Crown Reserve has not identified a target or signed any Business Combination agreement.